{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,10]],"date-time":"2026-11-10T17:55:20Z","timestamp":1794333320617,"version":"4.9.0"},"reference-count":29,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2021,2,1]],"date-time":"2021-02-01T00:00:00Z","timestamp":1612137600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,2,1]],"date-time":"2021-02-01T00:00:00Z","timestamp":1612137600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"name":"University School of Medicine of Verona, Verona, Italy"},{"name":"Southampton National Institute for Health Research Biomedical Research Centre"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Diabetes & Metabolism"],"published-print":{"date-parts":[[2021,2]]},"DOI":"10.1016\/j.diabet.2020.03.003","type":"journal-article","created":{"date-parts":[[2020,4,10]],"date-time":"2020-04-10T05:54:08Z","timestamp":1586498048000},"page":"101152","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":41,"title":["Association between increased plasma ceramides and chronic kidney disease in patients with and without ischemic heart disease"],"prefix":"10.1016","volume":"47","author":[{"given":"A.","family":"Mantovani","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7271-6329","authenticated-orcid":false,"given":"G.","family":"Lunardi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"Bonapace","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.","family":"Dugo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Altomari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G.","family":"Molon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Conti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.","family":"Bovo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R.","family":"Laaksonen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.D.","family":"Byrne","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F.","family":"Bonnet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4325-3900","authenticated-orcid":false,"given":"G.","family":"Targher","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.diabet.2020.03.003_bib0150","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.plipres.2014.01.004","article-title":"Ceramide: a simple sphingolipid with unique biophysical properties","volume":"54","author":"Castro","year":"2014","journal-title":"Prog Lipid Res"},{"key":"10.1016\/j.diabet.2020.03.003_bib0155","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1038\/nrendo.2016.169","article-title":"Sphingolipids and phospholipids in insulin resistance and related metabolic disorders","volume":"13","author":"Meikle","year":"2017","journal-title":"Nat Rev Endocrinol"},{"key":"10.1016\/j.diabet.2020.03.003_bib0160","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1186\/s12944-015-0053-y","article-title":"Sphingolipids in cardiovascular diseases and metabolic disorders","volume":"14","author":"Borodzicz","year":"2015","journal-title":"Lipids Health Dis"},{"key":"10.1016\/j.diabet.2020.03.003_bib0165","doi-asserted-by":"crossref","first-page":"1967","DOI":"10.1093\/eurheartj\/ehw148","article-title":"Plasma ceramides predict cardiovascular death in patients with stable coronary artery disease and acute coronary syndromes beyond LDL-cholesterol","volume":"37","author":"Laaksonen","year":"2016","journal-title":"Eur Heart J"},{"key":"10.1016\/j.diabet.2020.03.003_bib0170","doi-asserted-by":"crossref","first-page":"2424","DOI":"10.1161\/ATVBAHA.116.307497","article-title":"Circulating ceramides predict cardiovascular outcomes in the population-based FINRISK 2002 cohort","volume":"36","author":"Havulinna","year":"2016","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.diabet.2020.03.003_bib0175","doi-asserted-by":"crossref","first-page":"1729","DOI":"10.1194\/jlr.P081281","article-title":"Plasma concentrations of molecular lipid species predict long-term clinical outcome in coronary artery disease patients","volume":"59","author":"Anroedh","year":"2018","journal-title":"J Lipid Res"},{"key":"10.1016\/j.diabet.2020.03.003_bib0180","doi-asserted-by":"crossref","first-page":"2028","DOI":"10.1161\/CIRCULATIONAHA.116.024261","article-title":"Plasma ceramides, Mediterranean diet, and incident cardiovascular disease in the PREDIMED trial (Prevenci\u00f3n con Dieta Mediterr\u00e1nea)","volume":"135","author":"Wang","year":"2017","journal-title":"Circulation"},{"key":"10.1016\/j.diabet.2020.03.003_bib0185","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1093\/eurheartj\/ehz387","article-title":"Development and validation of a ceramide- and phospholipid-based cardiovascular risk estimation score for coronary artery disease patients","volume":"41","author":"Hilvo","year":"2020","journal-title":"Eur Heart J"},{"key":"10.1016\/j.diabet.2020.03.003_bib0190","doi-asserted-by":"crossref","DOI":"10.1016\/j.jacl.2020.01.005","article-title":"Ceramides and risk of major adverse cardiovascular events: a meta-analysis of longitudinal studies","author":"Mantovani","year":"2020","journal-title":"J Clin Lipid"},{"key":"10.1016\/j.diabet.2020.03.003_bib0195","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1016\/j.metabol.2018.05.006","article-title":"G Canali, et al. Association between plasma ceramides and inducible myocardial ischemia in patients with established or suspected coronary artery disease undergoing myocardial perfusion scintigraphy","volume":"85","author":"Mantovani","year":"2018","journal-title":"Metabolism"},{"key":"10.1016\/j.diabet.2020.03.003_bib0200","article-title":"Associations between specific plasma ceramides and severity of coronary-artery stenosis assessed by coronary angiography","author":"Mantovani","year":"2019","journal-title":"Diabetes Metab"},{"key":"10.1016\/j.diabet.2020.03.003_bib0205","doi-asserted-by":"crossref","first-page":"e0158765","DOI":"10.1371\/journal.pone.0158765","article-title":"Global Prevalence of chronic kidney disease \u2013 a systematic review and meta-analysis","volume":"11","author":"Hill","year":"2016","journal-title":"PLoS One"},{"key":"10.1016\/j.diabet.2020.03.003_bib0210","doi-asserted-by":"crossref","first-page":"1238","DOI":"10.1016\/S0140-6736(16)32064-5","article-title":"Chronic kidney disease","volume":"389","author":"Webster","year":"2017","journal-title":"Lancet"},{"key":"10.1016\/j.diabet.2020.03.003_bib0215","doi-asserted-by":"crossref","first-page":"825","DOI":"10.7326\/0003-4819-158-11-201306040-00007","article-title":"Guideline evaluation and management of chronic kidney disease: synopsis of the Kidney Disease: Improving Global Outcomes 2012 Clinical","volume":"158","author":"Stevens","year":"2014","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.diabet.2020.03.003_bib0220","doi-asserted-by":"crossref","first-page":"825","DOI":"10.7326\/0003-4819-158-11-201306040-00007","article-title":"Guideline evaluation and management of chronic kidney disease: synopsis of the kidney disease: improving global outcomes 2012 clinical","volume":"158","author":"Stevens","year":"2014","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.diabet.2020.03.003_bib0225","article-title":"Screening for non-alcoholic fatty liver disease using liver stiffness measurement and its association with chronic kidney disease and cardiovascular complications in patients with type 2 diabetes","author":"Mantovani","year":"2019","journal-title":"Diabetes Metab"},{"key":"10.1016\/j.diabet.2020.03.003_bib0230","doi-asserted-by":"crossref","first-page":"604","DOI":"10.7326\/0003-4819-150-9-200905050-00006","article-title":"A new equation to estimate glomerular filtration rate","volume":"150","author":"Levey","year":"2009","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.diabet.2020.03.003_bib0235","doi-asserted-by":"crossref","first-page":"2854","DOI":"10.1161\/ATVBAHA.118.311927","article-title":"Association of plasma ceramides with myocardial perfusion in patients with coronary artery disease undergoing stress myocardial perfusion scintigraphy","volume":"38","author":"Mantovani","year":"2018","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.diabet.2020.03.003_bib0240","article-title":"Preanalytical biases in the measurement of human blood sphingolipids","volume":"19","author":"Brunkhorst","year":"2018","journal-title":"Int J Mol Sc"},{"key":"10.1016\/j.diabet.2020.03.003_bib0245","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1007\/s00467-013-2642-1","article-title":"Ceramides and cardiac function in children with chronic kidney disease","volume":"29","author":"Mitsnefes","year":"2014","journal-title":"Pediatr Nephrol"},{"key":"10.1016\/j.diabet.2020.03.003_bib0250","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1016\/j.ekir.2016.12.003","article-title":"Profiling of plasma metabolites suggests altered mitochondrial fuel usage and remodeling of sphingolipid metabolism in individuals with type 2 diabetes and kidney disease","volume":"2","author":"Liu","year":"2016","journal-title":"Kidney Int Rep"},{"key":"10.1016\/j.diabet.2020.03.003_bib0255","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1007\/s11154-016-9402-z","article-title":"Dyslipidemia in patients with chronic kidney disease","volume":"18","author":"Hager","year":"2017","journal-title":"Rev Endocr Metab Disord"},{"key":"10.1016\/j.diabet.2020.03.003_bib0260","doi-asserted-by":"crossref","first-page":"127","DOI":"10.3389\/fendo.2014.00127","article-title":"Podocyte pathology and nephropathy \u2013 sphingolipids in glomerular diseases","volume":"5","author":"Merscher","year":"2014","journal-title":"Front Endocrinol (Lausanne)"},{"key":"10.1016\/j.diabet.2020.03.003_bib0265","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1016\/j.matbio.2018.01.006","article-title":"Sphingolipid signaling in renal fibrosis","volume":"68\u201369","author":"Huwiler","year":"2018","journal-title":"Matrix Biol"},{"key":"10.1016\/j.diabet.2020.03.003_bib0270","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1038\/nature13475","article-title":"Sphingolipid metabolites in inflammatory disease","volume":"510","author":"Maceyka","year":"2014","journal-title":"Nature"},{"key":"10.1016\/j.diabet.2020.03.003_bib0275","doi-asserted-by":"crossref","first-page":"1858","DOI":"10.1172\/JCI43378","article-title":"Lipid-induced insulin resistance mediated by the proinflammatory receptor TLR4 requires saturated fatty acid-induced ceramide biosynthesis in mice","volume":"121","author":"Holland","year":"2011","journal-title":"J Clin Invest"},{"key":"10.1016\/j.diabet.2020.03.003_bib0280","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.plipres.2015.09.002","article-title":"Control of inflammatory responses by ceramide, sphingosine 1-phosphate and ceramide 1-phosphate","volume":"61","author":"Gomez-Mu\u00f1oz","year":"2016","journal-title":"Prog Lipid Res"},{"key":"10.1016\/j.diabet.2020.03.003_bib0285","article-title":"Association between specific plasma ceramides and high-sensitivity C-reactive protein levels in postmenopausal women with type 2 diabetes","author":"Mantovani","year":"2019","journal-title":"Diabetes Metab"},{"key":"10.1016\/j.diabet.2020.03.003_bib0290","doi-asserted-by":"crossref","first-page":"1238","DOI":"10.2174\/0929867324666170112114525","article-title":"Sphingolipids in genetic and acquired forms of chronic kidney diseases","volume":"24","author":"Ueda","year":"2017","journal-title":"Curr Med Chem"}],"container-title":["Diabetes & Metabolism"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1262363620300513?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1262363620300513?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T10:56:51Z","timestamp":1761130611000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1262363620300513"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,2]]},"references-count":29,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2021,2]]}},"alternative-id":["S1262363620300513"],"URL":"https:\/\/doi.org\/10.1016\/j.diabet.2020.03.003","relation":{},"ISSN":["1262-3636"],"issn-type":[{"value":"1262-3636","type":"print"}],"subject":[],"published":{"date-parts":[[2021,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Association between increased plasma ceramides and chronic kidney disease in patients with and without ischemic heart disease","name":"articletitle","label":"Article Title"},{"value":"Diabetes & Metabolism","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.diabet.2020.03.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier Masson SAS. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"101152"}}